X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (191) 191
infectious diseases (160) 160
male (159) 159
female (151) 151
adult (143) 143
hiv infections - drug therapy (121) 121
index medicus (111) 111
hiv (110) 110
middle aged (99) 99
virology (84) 84
immunology (82) 82
aids (77) 77
viral load (73) 73
cohort studies (71) 71
cd4 lymphocyte count (69) 69
hiv infections - virology (66) 66
risk factors (59) 59
antiretroviral therapy (57) 57
anti-hiv agents - therapeutic use (55) 55
disease progression (47) 47
hiv infection (46) 46
human immunodeficiency virus--hiv (46) 46
antiretroviral therapy, highly active (43) 43
antiretroviral drugs (42) 42
drug therapy (42) 42
highly active antiretroviral therapy (42) 42
antiviral agents (41) 41
aged (40) 40
hiv infections - immunology (39) 39
research (39) 39
drug therapy, combination (35) 35
health aspects (35) 35
hiv-1 - drug effects (35) 35
microbiology (35) 35
human immunodeficiency virus (33) 33
mortality (33) 33
hiv infections - complications (32) 32
infection (32) 32
hiv-1 - genetics (29) 29
rna, viral - blood (29) 29
therapy (29) 29
time factors (29) 29
treatment outcome (29) 29
adolescent (28) 28
cohort (28) 28
pharmacology & pharmacy (28) 28
treatment failure (28) 28
antiretrovirals (27) 27
care and treatment (27) 27
infections (27) 27
regression analysis (27) 27
viruses (27) 27
aids/hiv (26) 26
hiv-1 (26) 26
risk (26) 26
acquired immune deficiency syndrome--aids (25) 25
epidemiology (25) 25
individuals (25) 25
medicine (24) 24
patients (24) 24
young adult (24) 24
active antiretroviral therapy (23) 23
europe (23) 23
genotype (23) 23
human-immunodeficiency-virus (23) 23
rna (23) 23
prospective studies (22) 22
research article (22) 22
acquired immune deficiency syndrome (21) 21
hiv-1-infected patients (21) 21
reverse transcriptase inhibitors - therapeutic use (21) 21
settore med/17 - malattie infettive (21) 21
analysis (20) 20
anti-hiv agents - administration & dosage (20) 20
prognosis (20) 20
protease inhibitors (20) 20
antiretroviral agents (19) 19
drug resistance, viral (19) 19
hiv infections (19) 19
incidence (19) 19
infected patients (19) 19
multidisciplinary sciences (19) 19
mutation (19) 19
hiv patients (18) 18
italy (18) 18
anti-hiv agents - pharmacology (17) 17
drug resistance, viral - genetics (17) 17
hiv/aids (17) 17
prevalence (17) 17
science (17) 17
cd4 antigen (16) 16
hiv 1 (16) 16
hiv infections - mortality (16) 16
italy - epidemiology (16) 16
medical research (16) 16
anti-retroviral agents - therapeutic use (15) 15
antivirals (15) 15
drug resistance (15) 15
hiv infections - epidemiology (15) 15
hiv protease inhibitors - therapeutic use (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Infectious Diseases, ISSN 1471-2334, 09/2013, Volume 13, Issue 1, pp. 414 - 414
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2011, Volume 11, Issue 5, pp. 363 - 371
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, p. e0177402
Background Real-life data on access and response to direct antiviral agents (DAA) in HIV-HCV co-infected individuals are lacking. Methods HCV viremic,... 
GENOTYPE 1 | COINFECTED PATIENTS | VIRUS | SOFOSBUVIR PLUS RIBAVIRIN | HIV/HCV | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | BOCEPREVIR | ANTIRETROVIRAL THERAPY | HEPATITIS-C | LEDIPASVIR | Coinfection | Hepatitis C - drug therapy | HIV Infections - epidemiology | Humans | Middle Aged | Hepacivirus - genetics | Male | Viral Load | Health Services Accessibility | Hepatitis C - epidemiology | Treatment Failure | Adult | Female | HIV Infections - transmission | Antiviral Agents - therapeutic use | Comorbidity | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Genotype | Treatment Outcome | CD4 Lymphocyte Count | Antiretroviral Therapy, Highly Active | HIV Infections - drug therapy | Italy - epidemiology | Disease Management | Highly active antiretroviral therapy | Hepatitis C | Drug therapy | HIV infection | Patient outcomes | Therapy | Ritonavir | Liver | Colleges & universities | Chronic infection | Biochemistry | Epidemiology | Hepatitis | Liver cancer | Acquired immune deficiency syndrome--AIDS | Surgery | Human immunodeficiency virus--HIV | Stiffness | Public health | Antiretroviral drugs | Liver diseases | Statistical tests | Patients | Cirrhosis | Disease transmission | Infectious diseases | Fibrosis | Death | Adults | Ascites | Hepatic encephalopathy | Liver transplantation | Drugs | Toxicity | Medical services | Clinical trials | Population studies | Viruses | Transplantation | Infections | Medical diagnosis | Bleeding | Guidelines | Antiretroviral agents | Intestine | Hepatology | Children | Continuity (mathematics) | Antiviral agents | Cryoglobulinemia | Health | Complications | Health risks | Light emitting diodes | Ribonucleic acid--RNA | Lymphoma | Adhesion | Medicine | Algorithms | Interferon | Diabetes | Cancer | RNA | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus | Ribonucleic acid | HIV
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2016, Volume 11, Issue 5, p. e0155100
Journal Article
Science, ISSN 0036-8075, 8/2007, Volume 317, Issue 5840, pp. 944 - 947
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2007, Volume 196, Issue 8, pp. 1180 - 1190
Journal Article
by Mondi, Annalisa and Cozzi‐Lepri, Alessandro and Tavelli, Alessandro and Rusconi, Stefano and Vichi, Francesca and Ceccherini‐Silberstein, Francesca and Calcagno, Andrea and De Luca, Andrea and Maggiolo, Franco and Marchetti, Giulia and Antinori, Andrea and d'Arminio Monforte, Antonella and Andreoni, M and Castagna, A and Castelli, F and Cauda, R and Di Perri, G and Galli, M and Iardino, R and Ippolito, G and azzarin, A and Rezza, G and Schloesser, F and Viale, P and Ceccherini‐Silberstein, F and Cozzi‐Lepri, A and Girardi, E and Lo Caputo, S and Mussini, C and Puoti, M and Perno, CF and Balotta, C and Bandera, A and Bonora, S and Borderi, M and Capetti, A and Capobianchi, MR and Cicalini, S and Cingolani, A and Cinque, P and Di Biagio, A and Gianotti, N and Gori, A and Guaraldi, G and Lapadula, G and Lichtner, M and Madeddu, G and Maggiolo, F and Monno, L and Nozza, S and Quiros Roldan, E and Rossotti, R and Rusconi, S and Santoro, MM and aracino, A and Sarmati, L and Fanti, I and Galli, L and Lorenzini, P and Rodano’, A and Macchia, M and Tavelli, A and Carletti, F and Carrara, S and Di Caro, A and Graziano, S and Petrone, F and Prota, G and Quartu, S and Truffa, S and Giacometti, Italy A and Costantini, A and Barocci, V and Angarano, G and Fabrizio, C and Suardi, C and i, V and Verucchi, G and Castelnuovo, F and Minardi, C and Menzaghi, B and Abeli, C and Cacopardo, B and Celesia, B and Vecchiet, J and Falasca, K and Pan, A and Lorenzotti, S and Sighinolfi, L and Segala, D and Blanc, P and Cassola, G and Viscoli, C and lessandrini, A and Bobbio, N and Mazzarello, G and Pozzetto, I and Bonfanti, P and Molteni, C and Chiodera, A and ... and Icona Fdn Study Grp and Icona Foundation Study Group
Journal of the International AIDS Society, ISSN 1758-2652, 01/2019, Volume 22, Issue 1, pp. e25227 - n/a
Introduction Concerns about dolutegravir (DTG) tolerability in the real‐life setting have recently arisen. We aimed to estimate the risk of treatment... 
toxicity | cohort study | dolutegravir | adverse events | antiretroviral therapy | discontinuation | INFECTIOUS DISEASES | ONCE-DAILY DOLUTEGRAVIR | RALTEGRAVIR | OPEN-LABEL | IMMUNOLOGY | NON-INFERIORITY | MAINTENANCE | TOLERABILITY | DOUBLE-BLIND | NAIVE ADULTS | Studies | Antiretroviral drugs | Survival analysis | Immunology | Failure analysis | Clinical trials | Drug therapy
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, p. e0186549
Journal Article
PLoS Genetics, ISSN 1553-7390, 12/2009, Volume 5, Issue 12, p. e1000791
Journal Article
Journal Article